- Type / Class
- Equity / Common Stock
- Shares outstanding
- 79,310,345
- Total 13F shares
- 12,045,335
- Share change
- +32,275
- Total reported value
- $81,792,858
- Put/Call ratio
- 80%
- Price per share
- $6.79
- Number of holders
- 85
- Value change
- -$12,039,617
- Number of buys
- 36
- Number of sells
- 51
Quarterly Holders Quick Answers
What is CUSIP 21900C308?
CUSIP 21900C308 identifies CRMD - CorMedix Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 21900C308:
Top shareholders of CRMD - CorMedix Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.5%
from 13D/G
|
5,776,428
|
$67,179,857 | — | 31 Dec 2025 | |
| Deep Track Capital, LP |
13F
13D/G
|
Company |
6.3%
from 13D/G
|
5,274,076
|
$61,337,504 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.7%
|
4,499,010
|
$52,323,486 | — | 31 Dec 2025 | |
| Aymen Abdalkader Shaibatalhamd |
13D/G
|
SHAIBATALHAMD AYMEN ABDALKADER |
5.8%
|
4,600,000
|
$44,390,000 | -$440,330 | 01 Jan 2026 | |
| MARSHALL WACE, LLP |
13F
|
Company |
2.5%
|
1,966,262
|
$22,867,628 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
1,920,861
|
$22,339,613 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
1,912,233
|
$22,242,743 | — | 31 Dec 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.4%
|
1,107,944
|
$12,885,389 | — | 31 Dec 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
1.1%
|
850,000
|
$9,885,500 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
828,781
|
$9,638,723 | — | 31 Dec 2025 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
1%
|
805,115
|
$9,363,487 | — | 31 Dec 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.83%
|
658,105
|
$7,653,761 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.82%
|
648,762
|
$7,545,108 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.8%
|
636,035
|
$7,397,088 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.77%
|
614,598
|
$7,147,775 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.77%
|
610,928
|
$7,105,093 | — | 31 Dec 2025 | |
| Palisades Investment Partners, LLC |
13F
|
Company |
0.73%
|
576,759
|
$6,707,707 | — | 31 Dec 2025 | |
| Joseph Todisco |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
1,185,994
mixed-class rows
|
$5,469,727 | -$1,010,000 | 04 Feb 2026 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.59%
|
465,441
|
$5,413,078 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.54%
|
432,215
|
$5,026,660 | — | 31 Dec 2025 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.48%
|
378,537
|
$4,402,391 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.48%
|
376,907
|
$4,383,429 | — | 31 Dec 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.4%
|
320,997
|
$3,733,195 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.4%
|
320,150
|
$3,723,344 | — | 31 Dec 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.4%
|
314,970
|
$3,663,101 | — | 31 Dec 2025 | |
| October Effect Ltd |
13F
|
Company |
0.39%
|
306,444
|
$3,563,944 | — | 31 Dec 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.38%
|
302,508
|
$3,518,168 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.36%
|
288,884
|
$3,359,721 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.35%
|
279,026
|
$3,245,073 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.35%
|
274,630
|
$3,193,947 | — | 31 Dec 2025 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.34%
|
271,690
|
$3,159,755 | — | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.33%
|
262,601
|
$3,054,009 | — | 31 Dec 2025 | |
| Myron Kaplan |
3/4/5
|
Director |
0.33%
|
261,487
|
$3,041,093 | +$275,500 | 26 Jan 2026 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.32%
|
253,896
|
$2,952,810 | — | 31 Dec 2025 | |
| Swedbank AB |
13F
|
Company |
0.32%
|
250,000
|
$2,907,500 | — | 31 Dec 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.31%
|
242,023
|
$2,814,727 | — | 31 Dec 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.29%
|
229,436
|
$2,668,341 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.28%
|
221,760
|
$2,579,069 | — | 31 Dec 2025 | |
| Del-Sette Capital Management, LLC |
13F
|
Company |
0.27%
|
210,831
|
$2,451,965 | — | 31 Dec 2025 | |
| HUSSMAN STRATEGIC ADVISORS, INC. |
13F
|
Company |
0.26%
|
210,000
|
$2,442,300 | — | 31 Dec 2025 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0.26%
|
204,485
|
$2,378,161 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.23%
|
181,106
|
$2,106,263 | — | 31 Dec 2025 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.23%
|
179,980
|
$2,093,167 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.22%
|
173,982
|
$2,023,411 | — | 31 Dec 2025 | |
| Phocas Financial Corp. |
13F
|
Company |
0.22%
|
171,087
|
$1,989,742 | — | 31 Dec 2025 | |
| VARCOV Co. |
13F
|
Company |
0.22%
|
170,890
|
$1,987,451 | — | 31 Dec 2025 | |
| Elizabeth Hurlburt |
3/4/5
|
Chief Operating Officer |
0.35%
|
278,539
|
$1,966,485 | -$711,817 | 04 Feb 2026 | |
| Beth Zelnick Kaufman |
3/4/5
|
Chief Legal Officer |
—
mixed-class rows
|
419,108
mixed-class rows
|
$1,899,902 | -$670,264 | 04 Feb 2026 | |
| Steven W. Lefkowitz |
3/4/5
|
Director |
0.2%
|
158,103
|
$1,838,737 | -$475,200 | 26 Jan 2026 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.2%
|
155,050
|
$1,803,232 | — | 31 Dec 2025 |
Institutional Holders of CorMedix Inc. - Common Stock (CRMD) as of Q1 2026
As of 31 Mar 2026,
CorMedix Inc. - Common Stock (CRMD) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,045,335 shares.
The largest 10 holders included
VANGUARD CAPITAL MANAGEMENT LLC, ROYCE & ASSOCIATES LP, UBS Group AG, VANGUARD PORTFOLIO MANAGEMENT LLC, Palisades Investment Partners, LLC, VANGUARD FIDUCIARY TRUST CO, Private Advisor Group, LLC, Bank of New York Mellon Corp, NEW YORK STATE COMMON RETIREMENT FUND, and Steward Partners Investment Advisory, LLC.
This page lists
85
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
200
Q1 2026 holders
85
Holder diff
-115
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.